Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002
- PMID: 17141362
- DOI: 10.1016/j.jaad.2006.09.006
Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002
Abstract
Background: The epidemiology of dermatofibrosarcoma protuberans (DFSP) has not been studied in detail.
Objective: We sought to describe patterns of DFSP incidence and survival in the United States.
Methods: Data were obtained from 9 population-based cancer registries of the Surveillance, Epidemiology, and End Results Program for 1973 to 2002.
Results: DFSP overall annual incidence was 4.2 per million. Incidence increased by 43% (3.1-4.4 per million per year) during the study period, but this increase was restricted to whites. Annual incidence among blacks (6.5 per million) was almost double the incidence among whites (3.9 per million; P < .005, 95% confidence interval of difference 2.02-3.22). Women had higher rates of incidence than men (4.4 vs 4.2 per million per year; P = .052, 95% confidence interval of difference -0.002 to 0.60), except among the elderly. Relative 5-year survival was 99.2% (95% confidence interval 98.3-100%).
Limitations: The Surveillance, Epidemiology, and End Results Program lacks independent verification of diagnoses and case detail.
Conclusions: The racial differences in the incidence of DFSP are significant, and the cause is unknown. Previous literature had suggested that men were more frequently affected, which was not true in our data. The tumor rarely results in death. Epidemiologic investigation using population-based data is important to better understand this disorder.
Similar articles
-
Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.Dermatol Surg. 2016 Jan;42 Suppl 1:S24-31. doi: 10.1097/DSS.0000000000000300. Dermatol Surg. 2016. PMID: 26730971
-
The epidemiology of dermatofibrosarcoma protuberans incidence, metastasis, and death among various population groups: A Surveillance, Epidemiology, and End Results database analysis.J Am Acad Dermatol. 2024 Nov;91(5):826-833. doi: 10.1016/j.jaad.2024.05.088. Epub 2024 Jun 21. J Am Acad Dermatol. 2024. PMID: 38908718
-
Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.J Am Acad Dermatol. 2013 May;68(5):790-6. doi: 10.1016/j.jaad.2012.10.040. Epub 2012 Dec 21. J Am Acad Dermatol. 2013. PMID: 23261548
-
Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.Dermatol Surg. 2012 Sep;38(9):1461-8. doi: 10.1111/j.1524-4725.2012.02482.x. Epub 2012 Jun 12. Dermatol Surg. 2012. PMID: 22691126
-
Dermatofibrosarcoma protuberans: a clinicopathological study in an African population.East Afr Med J. 1996 Jun;73(6):410-3. East Afr Med J. 1996. PMID: 8840606 Review.
Cited by
-
Bednar's tumor at right shoulder in an adult male: a case report of a rare entity.Ann Med Surg (Lond). 2024 Jan 3;86(2):1196-1199. doi: 10.1097/MS9.0000000000001672. eCollection 2024 Feb. Ann Med Surg (Lond). 2024. PMID: 38333248 Free PMC article.
-
A rare case of dermatofibrosarcoma protuberans of the forefoot.Radiol Case Rep. 2016 Apr 4;11(2):102-5. doi: 10.1016/j.radcr.2016.02.013. eCollection 2016 Jun. Radiol Case Rep. 2016. PMID: 27257461 Free PMC article.
-
Dermatofibrosarcoma protuberans associated with trauma: A case report.Mol Clin Oncol. 2020 Nov;13(5):51. doi: 10.3892/mco.2020.2121. Epub 2020 Aug 20. Mol Clin Oncol. 2020. PMID: 32874581 Free PMC article.
-
Dermatofibrosarcoma Protuberans.Curr Treat Options Oncol. 2017 Aug 10;18(9):56. doi: 10.1007/s11864-017-0498-5. Curr Treat Options Oncol. 2017. PMID: 28795284 Review.
-
Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib.World J Surg Oncol. 2013 Mar 8;11:59. doi: 10.1186/1477-7819-11-59. World J Surg Oncol. 2013. PMID: 23496933 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources